A Primer on Skin Cancers Cathryn Zhang, MD University of Arizona 3/8/14.
-
Upload
madeleine-oliver -
Category
Documents
-
view
214 -
download
1
Transcript of A Primer on Skin Cancers Cathryn Zhang, MD University of Arizona 3/8/14.
A Primer on Skin A Primer on Skin CancersCancers
Cathryn Zhang, MDUniversity of Arizona3/8/14
ObjectivesObjectives1. Review the major types of skin
cancers (basal cell carcinoma, squamous cell carcinoma, melanoma)
2. Describe the treatment options for skin cancers
3. Recognize the risk of skin cancers arising in chronic wounds (specifically SCCs, termed Marjolin's ulcer)
Skin Cancer Disease Skin Cancer Disease BurdenBurden
Very common, especially in individuals with fair complexion
Estimated annual cases: 3.5 million
1 in 5 Americans will develop skin cancer in their lifetime
Amount of annual UV radiation correlates with incidence
National Cancer Institute National Cancer Institute statsstats
More than 3.5 million nonmelanoma skin cancers are diagnosed annually.
Types of skin cancersTypes of skin cancersBCC: 2.8 million cases annuallySCC: 700,000 cases annually Melanoma: 76,690 cases in 2013Other types comprise < 1% of skin
cancers: cutaneous lymphomas (CTCL, CBCL and all their variants), leukemia cutis, Merkel cell carcinoma, DFSP, AFX, Kaposi’s sarcoma, angiosarcoma, liposarcoma, Paget’s disease, EMPD, MAC, clear cell sarcoma, pilomatrix carcinoma, sebaceous carcinoma, adenoid cystic carcinoma, eccrine porocarcinoma, mucinous carcinoma, hidradenocarcinoma, eccrine ductal carcinoma, apocrine carcinoma, superficial malignant fibrous histiocytoma, epithelioid sarcoma, malignant peripheral nerve sheath tumor, leiomyosarcoma, cutaneous metastases, etc.
BASAL CELL CARCINOMABASAL CELL CARCINOMA
Basal cell carcinomaBasal cell carcinomaBasaloid cells which appear similar to
cells in the basal layer of the epidermisThought to arise from pluripotent stem
cells within hair folliclesTypes:
◦ Nodular: up to 80% ◦ Superficial◦ Morpheaform◦ Fibroepithelial
Arises in sun-damaged skin Can ulcerateOccasionally can be pigmented
Nodular BCCNodular BCC• Most common subtype• Primary lesion• Shiny, pearly papule or nodule• Smooth surface• Arborizing telangiectasias
• Ulcerate with enlargement ,“rodent ulcer”• Face (cheeks, melolabial folds,
forehead, eyelids), any hair-bearing area of skin
Superficial BCCSuperficial BCC
Well-circumscribed, erythematous macule/patch or thin papule/plaque
Few mm to several cmFocal scale and/or crustThin rolled borderSpontaneous regression in larger
lesionsFavors trunk and extremities
Morpheaform BCCMorpheaform BCCLess common aggressive subtypePrimary lesion
◦Slightly elevated or depressed indurated light pink to white patch/plaque
◦Ill-defined borders◦Resembles scar ◦Smooth +/- crusts, erosions, ulcerations◦+/- telangiectasia◦Absence of rolled border
Fibroepithelial BCC Fibroepithelial BCC (Fibroepithelioma of Pinkus)(Fibroepithelioma of Pinkus)
Skin-colored or pink pedunculated papulonodule with smooth surface
Can resemble acrochordon or an intradermal nevus
Favors trunk (lower back)
PrognosisPrognosisUsually slow growing with local
extensionMetastases extremely rare:
0.0028-0.55%◦Lymph node most common ◦Lung, bone, distant skin, liver, pleura
Rare cause for mortality: 0.12/100,000 (0.00012%)
TreatmentsTreatmentsMohs micrographic surgeryExcisionED&C (electrodessication and
curettage) CryotherapyTopical (superficial subtype only)
◦ Imiquimod◦Fluorouracil
XRT Photodynamic therapyVismodegib: smoothened inhibitor
Excision vs MohsExcision vs Mohs
TreatmentsTreatmentsMohs micrographic surgeryExcisionED&C (electrodessication and
curettage) CryotherapyTopical (superficial subtype only)
◦ Imiquimod◦Fluorouracil
XRT Photodynamic therapyVismodegib: smoothened inhibitor
ED&CED&C
TreatmentsTreatmentsMohs micrographic surgeryExcisionED&C (electrodessication and
curettage) CryotherapyTopical (superficial subtype only)
◦ Imiquimod◦Fluorouracil
XRT Photodynamic therapyVismodegib: smoothened inhibitor
SQUAMOUS CELL SQUAMOUS CELL CARCINOMACARCINOMA
Actinic keratosis (AK)Actinic keratosis (AK)Syn: solar keratosis, senile keratosisSyn: solar keratosis, senile keratosis
Pre-cancerousAtypical keratinocytes in the
basal layer of the epidermis (not full-thickness)
No risk of metastasisEvolution to SCC: 0.075-0.096%
per lesion per year estimated 5% chance of developing SCC over 5-10 years.
Actinic KeratosisActinic Keratosis
Clinical features• Present on sun-damaged skin• Head, neck, upper trunk and extensor
extremities• Cluster in areas of highest sun exposure• Superior helices of ears• Upper forehead• Supraorbital ridge• Nasal bridge• Malar eminences• Dorsal hands• Extensor forearms• Bald scalp
Actinic KeratosisActinic KeratosisClinical features• Primary lesion• Rough erythematous papule with white
to yellow scale• +/- tenderness• Few mm to confluent patches several cm• Early sign: slight erythema with
imperceptible scale• Clues: background photodamage
(dyspigmentation, telangiectasia, wrinkling)• Advanced lesion: thicker, better defined
Actinic Keratosis VariantsActinic Keratosis VariantsHyperkeratotic/hypertrophic
◦Papules, plaques with scale or scale-crust on an erythematous base
◦Base extends beyond overlying hyperkeratosis
Pigmented AK ◦Usually lacks erythema◦Hyperpigmented/reticulated
appearance
Actinic Keratosis VariantsActinic Keratosis Variants
Lichenoid AK◦Dx histopathologically by dense, band-
like inflammatory infiltrate◦More erythema than traditional AK
Atrophic◦Minimal surface change◦Pink/red slightly scaly macule or patch
Actinic cheilitis◦Lower vermilion lip◦Classic vs diffuse◦+/- leukoplakia
TreatmentsTreatmentsCryotherapy: >99%Topical therapies:
◦Fluorouracil: 50% have 100% clearance◦Imiquimod: 50% have 100% clearance ◦Diclofenac: 40% clearance◦Ingenol mebutate: 34-47% clearance rate◦Retinoids: mixed results
Photodynamic therapy: 50-70% clearance
Surgical: Shave removal or curettage
AKsAKsConsider removal:
◦pearly or glassy appearance◦palpable dermal component◦> 6mm◦persistence after multiple treatments